ESCRS - Genetic factors of myopia

Genetic factors of myopia

Genetic factors of myopia

A new genetic study supports the hypothesis that high myopia has an important hereditary component in the Chinese population. The study evaluated the association of single nucleotide polymorphisms (SNPs) in 321 individuals with pathological myopia and 310 control individuals with normal vision. The analysis revealed significant differences in the distribution of variants of the SNP rs1479617 located in the CTNND2 gene and 11q21.1 regions between the high myopes and control individuals. Previous research has implicated the same region of the CTNND2 gene and 11q21.1 regions in high myopia in this Chinese population. The authors speculated that the variant in the CTNND2 gene may alter the behaviour of scleral fibroblasts, allowing the eye to lengthen abnormally, possibly in response to environmental factors.

(Yu et al, Ophthalmologica 2012; DOI: 10.1159/000338188.)

Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...